Variable	GFR		ACR
	Estimate (95% CI)	P-Value	Estimate (95% CI)	P-Value
Plasma Aldosterone	0 (−0.02, 0.01)	0.45	0.07 (−0.06, 0.2)	0.30
Plasma Renin Activity	−0.13 (−0.61, 0.34)	0.58	−2.23 (−7.19, 2.74)	0.38
Recipient Age (years)	−0.01 (−0.22, 0.19)	0.89	−0.39 (−2.18, 1.41)	0.67
Female Recipient	−2.8 (−7.41, 1.81)	0.23	2.25 (−37.64, 42.14)	0.91
Caucasian Recipient	−6.78 (−13.55, −0.01)	0.05	−3.68 (−62.07, 54.71)	0.90
Recipient BMI	−0.13 (−0.62, 0.36)	0.59	−2.35 (−6.6, 1.89)	0.27
SBP (mmHg)	0.03 (−0.11, 0.16)	0.69	2.07 (0.72, 3.42)	<0.01
DBP (mmHg)	−0.01 (−0.25, 0.23)	0.94	−0.99 (−3.39, 1.4)	0.41
Hypertensive	2.37 (−2.69, 7.42)	0.36	32.57 (−10.89, 76.04)	0.14
Acute Rejection	−1.11 (−6.89, 4.67)	0.71	66.42 (16.03, 116.81)	0.01
<3 HLA Matches	−3.29 (−8.01, 1.44)	0.17	−24.64 (−65.65, 16.37)	0.24
Live Donor	2.66 (−3.12, 8.44)	0.36	−29.16 (−79.16, 20.83)	0.25
Donor Age (years)	−0.28 (−0.49, −0.07)	0.01	1.49 (−0.34, 3.32)	0.11
Female Donor	−4.02 (−8.86, 0.81)	0.10	19.53 (−22.46, 61.53)	0.36
Caucasian Donor	4.32 (−1.21, 9.85)	0.12	9.57 (−38.63, 57.77)	0.70
Cause of Kidney Disease
DM	reference		reference
HTN	−0.79 (−10.64, 9.06)	0.87	−38.75 (−123.41, 45.91)	0.37
PCKD	0.53 (−6.88, 7.93)	0.37	−12.6 (−77.3, 52.1)	0.70
Other	2.59 (−3.15, 8.33)	0.89	−57.85 (−108.47, −7.23)	0.03
Losartan	−1.6 (−6.21, 3)	0.49	3.43 (−36.8, 43.67)	0.87
Thiazides	0.44 (−7.81, 8.7)	0.92	−14.99 (−85.67, 55.7)	0.68
Loop Diuretics	−2.05 (−7.51, 3.42)	0.46	−28.15 (−75.47, 19.16)	0.24
Tacrolimus + Rapamycin	−2.7 (−12.46, 7.06)	0.59	−6.12 (−90.92, 78.69)	0.89
Tacrolimus + MMF + Pred.	−5.23 (−14.13, 3.66)	0.25	−37.23 (−114.55, 40.1)	0.34
Tacrolimus + MMF + Pred.	−5.17 (−16.9, 6.56)	0.38	−24.16 (−126.86, 78.55)	0.64
CSA + MMF	−9.35 (−18.71, 0)	0.05	−8.69 (−90.61, 73.22)	0.83
CSA + MMF + Pred.	−7.66 (−17.53, 2.22)	0.13	−14.26 (−100.15, 71.63)	0.74

SBP: systolic blood pressure; DBP: diastolic blood pressure; CSA: Cyclosporine